Page last updated: 2024-10-16

choline and Parkinson Disease, Secondary

choline has been researched along with Parkinson Disease, Secondary in 12 studies

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19906 (50.00)18.7374
1990's1 (8.33)18.2507
2000's3 (25.00)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hou, Z1
Zhang, Z1
Meng, H1
Lin, X1
Sun, B1
Lei, H1
Fang, K1
Fang, F1
Liu, M1
Liu, S1
Zhu, W1
An, Y1
Zheng, J1
Tang, L1
Zhang, W1
Jin, L1
Jiang, L1
Wächter, T1
Engeholm, M1
Bisdas, S1
Schittenhelm, J1
Gasser, T1
Krüger, R1
Yamasue, H1
Fukui, T1
Fukuda, R1
Kasai, K1
Iwanami, A1
Kato, N1
Kato, T1
Rango, M1
Canesi, M1
Ghione, I1
Farabola, M1
Righini, A1
Bresolin, N1
Antonini, A1
Pezzoli, G1
Federico, F1
Simone, IL1
Lucivero, V1
Iliceto, G1
De Mari, M1
Giannini, P1
Mezzapesa, DM1
Tarantino, A1
Lamberti, P1
Miller, RJ1
Hiley, CR1
Matthews, RT2
Chiou, CY2
Ruggieri, S1
Zamponi, A1
Casacchia, M1
Agnoli, A1
Van Woert, MH1
Sethy, VH1
Ambani, LM1
Koh, CV1
Ananth, JV1
Ban, TA1
Lehmann, HE1

Trials

2 trials available for choline and Parkinson Disease, Secondary

ArticleYear
[Therapeutic effects of cyticholine (cytidine-diphospho-choline) in Parkinsonian syndrome].
    La Clinica terapeutica, 1976, Sep-30, Volume: 78, Issue:6

    Topics: Adult; Aged; Choline; Clinical Trials as Topic; Cytidine Diphosphate Choline; Drug Evaluation; Femal

1976
Troxonium tosylate in the treatment of drug-induced extrapyramidal manifestations.
    Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology, 1971, Volume: 4, Issue:3

    Topics: Adult; Benzoates; Choline; Clinical Trials as Topic; Esters; Ethanol; Extrapyramidal Tracts; Female;

1971

Other Studies

10 other studies available for choline and Parkinson Disease, Secondary

ArticleYear
Parkinson's disease: in vivo metabolic changes in the frontal and parietal cortices in 6-OHDA treated rats during different periods.
    The International journal of neuroscience, 2014, Volume: 124, Issue:2

    Topics: Animals; Aspartic Acid; Choline; Corpus Striatum; Creatine; Disease Models, Animal; Frontal Lobe; Fu

2014
A new microdialysis-electrochemical device for in vivo simultaneous determination of acetylcholine and choline in rat brain treated with N-methyl-(R)-salsolinol.
    Biosensors & bioelectronics, 2009, Aug-15, Volume: 24, Issue:12

    Topics: Acetylcholine; Animals; Biosensing Techniques; Brain; Choline; Electrochemistry; Equipment Design; E

2009
Slowly progressive Parkinson syndrome due to thalamic butterfly astrocytoma.
    Neurology, 2011, Jul-26, Volume: 77, Issue:4

    Topics: Aged; Aspartic Acid; Astrocytoma; Brain Neoplasms; Brain Stem; Choline; Glial Fibrillary Acidic Prot

2011
Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
    The international journal of neuropsychopharmacology, 2003, Volume: 6, Issue:4

    Topics: Adult; Antipsychotic Agents; Aspartic Acid; Basal Ganglia Diseases; Choline; Chronic Disease; Creati

2003
Parkinson's disease, chronic hydrocarbon exposure and striatal neuronal damage: a 1-H MRS study.
    Neurotoxicology, 2006, Volume: 27, Issue:2

    Topics: Aged; Aspartic Acid; Choline; Creatine; Humans; Hydrocarbons; Magnetic Resonance Imaging; Magnetic R

2006
Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:6

    Topics: Aged; Antiparkinson Agents; Aspartic Acid; Atrophy; Cerebral Cortex; Choline; Corpus Striatum; Creat

1997
Anti-dopaminergic and anti-muscarinic effects of dibenzodiazepines: relationship to drug induced Parkinsonism.
    Naunyn-Schmiedeberg's archives of pharmacology, 1976, Volume: 292, Issue:3

    Topics: Adenylyl Cyclases; Animals; Cerebral Cortex; Choline; Clozapine; Corpus Striatum; Dibenzazepines; Di

1976
Effects of diethylcholine in two animal models of Parkinsonism tremors.
    European journal of pharmacology, 1979, Volume: 56, Issue:1-2

    Topics: Animals; Brain Chemistry; Carbachol; Choline; Disease Models, Animal; Male; Mice; Parkinson Disease,

1979
Cholinergic stimulation of the caudate nucleus in rats: a model of Parkinson's disease.
    Neuropharmacology, 1978, Volume: 17, Issue:10

    Topics: Animals; Caudate Nucleus; Choline; Disease Models, Animal; Injections; Male; Parasympathomimetics; P

1978
Effect of phenothiazines on central cholinergic activity.
    Advances in biochemical psychopharmacology, 1974, Volume: 9, Issue:0

    Topics: Acetylcholine; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Brain Chemistry; Chlorp

1974